Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$1.4M
1 round on record
Latest round
$1.4M
Venture round · Apr 2025 · 17 mo ago
Backers
1
50 Partners
The money's age
Due for its next round
17 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 9, 2025 Raised a round Venture round $1.4M · menafn
Funding rounds
RoundDateAmountInvestorsSource
Venture round Apr 2025 $1.4M — menafn
Registers and programsofficial lists and records that name the company
Legal entity Policy Medicud Srl its site
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Nanordica Medical‘s first-in-class wound care products are designed to prevent infection and promote wound closure simultaneously.
Company Company Innovative - Experienced - Growing. SERDA Therapeutics – a wholly owned subsidiary of Smith & Nephew – is a clinical-stage…
Transforming Wound Care with Technology.
PixacareFounded 2019 • 11-50 employees
Document, measure and coordinate wound healing with medical photography and AI. Certified medical AI, automated measurements and…
Sensore51-200 employees
Real-time pressure mapping and smart repositioning alerts, at home, in care and in clinic. Pre-order the S1 today.
AI-powered satellite analysis for Nature-based Solutions and supply chain monitoring. Accelerate development, measure impact, and ensure…

Overview

Medicud develops sustainable negative pressure wound therapy devices to improve surgical healing and reduce environmental impact.

News

News menafn 1 year ago
Medicud secures over €1.3M to initiate pivotal trial of innovative wound healing device
Medicud secures over €1.3M to initiate pivotal trial of innovative wound healing device. Financing will support clinical and regulatory development of DRYUM, novel and easy to use incisional negative pressure wound therapy system, with first clinical focu
Read more
Report

Financials

Total raised
$1.4M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 $1.4M Details